IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Birchview Capital, LP

Q2 2023 Holdings

Filed 2023-08-08 | 54 holdings | $133.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
Biodesix IncCOM09075X108$6.2M5,039,6334.6%
Neurocrine Biosciences Inc(NBIX)COM64125C109$7.9M84,2406.0%
Prothena Corp PLC(PRTA)SHSG72800108$10.7M156,1118.0%
Bristol-Myers Squibb Co(BMY)COM110122108$46.6M728,58534.9%
PreviousPage 2 of 2